JoergHerrmannMD
Cardiology • Rochester, MNAdult Congenital Heart Disease, Interventional Cardiology
Professor of Medicine
Dr. Herrmann is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St Sw
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Interventional Cardiology, 2010 - 2011- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Cardiovascular Disease, 2006 - 2010
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2003 - 2006
Ruhr - University Bochum Faculty of MedicineClass of 1997
Certifications & Licensure
IA State Medical License 2014 - 2025
MN State Medical License 2005 - 2025
WI State Medical License 2014 - 2025- American Board of Internal Medicine Cardiovascular Disease
Clinical Trials
- TrAstuzumab Cardiomyopathy Therapeutic Intervention With Carvedilol Start of enrollment: 2019 Aug 21
- Autophagy Activation for the Alleviation of Cardiomyopathy Symptoms After Anthracycline Treatment, ATACAR Trial Start of enrollment: 2020 Sep 01
Publications & Presentations
PubMed
- Novel risk score for predicting acute cardiovascular and cerebrovascular events after chest radiotherapy in patients with breast or lung cancer.Anan Abu Rmilah, Alkurashi Adham, Haq Ikram-Ul, Hossam Alzu'bi, Anevakar Nandan
European Journal of Preventive Cardiology. 2024-10-25 - 2 citationsCardiovascular toxicities of immune therapies for cancer - a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncol...Carlo Gabriele Tocchetti, Dimitrios Farmakis, Yvonne Koop, Maria Sol Andres, Liam S Couch
European Journal of Heart Failure. 2024-10-01 - Immune Checkpoint Inhibitor-Induced Cardiotoxicity: A Systematic Review and Meta-Analysis.Dorte Lisbet Nielsen, Carsten Bogh Juhl, Ole Haagen Nielsen, Inna Markovna Chen, Joerg Herrmann
JAMA Oncology. 2024-10-01
Lectures
- 10th Annual Mayo Clinic Interventional Cardiology Board ReviewMayo School of Continuous Professional Development, Rochester, Minnesota - 9/27/2013
- 10th Annual Mayo Clinic Interventional Cardiology Board ReviewMayo School of Continuous Professional Development, Rochester, Minnesota - 9/27/2013
Press Mentions
CV Admissions on the Rise in Americans with CancerAugust 9th, 2022- In Neurodegenerative Diseases, Research Finds Shared Gene Patterns, Widespread DamageFebruary 2nd, 2022
- Time Tempers Anthracyclines into a Toxin or Treatment for CancerJanuary 31st, 2022
- Join now to see all
Professional Memberships
- Member
Other Languages
- German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
